• Andersen K, Holm K, Tranberg M, Pedersen CL, Bønløkke S, Steiniche T, Andersen B, Stougaard M. Targeted Next Generation Sequencing for Human Papillomavirus Genotyping in Cervical Liquid-Based Cytology Samples. Cancers 14(3):652. doi.org/10.3390/cancers14030652
  
  
• Bonde J, Schroll JB, Kristensen BK, Lynge E, Waldstrøm M, Andersen B. Phased implementation of HPV-based cervical cancer screening in Denmark (in Danish). Ugeskr Laeger 184(9):V04210327. PMID: 35244023. 
  
  
• Eriksen ARR, Fogh K, Hasselbalch RB et al. SARS-CoV-2 antibody prevalence among homeless people and shelter workers in Denmark: a nationwide cross-sectional study. BMC Public Health 22: 1261. doi.org/10.1186/s12889-022-13642-7
  
  
• Flander L, Dekker E, Andersen B, Larsen MB, Steele RJ, Malila N, Sarkeala T, van der Vlugt M, de Klerk C, Knottnerus B, Bertels L, Woudstra A, Spaander MCW, Fransen M, Heinavaara S, Dillon M, Ait Ouakrim D, Jenkins M. What can We Learn From High-Performing Screening Programs to Increase Bowel Cancer Screening Participation in Australia? Cancer Control 29. doi.org/10.1177/10732748221121383 
  
  
• Fogh, K., Eriksen, A.R.R., Hasselbalch, R.B. et al. Seroprevalence of SARS-CoV-2 antibodies in social housing areas in Denmark. BMC Infect Dis 22, 143. Early online. doi.org/10.1186/s12879-022-07102-1
  
  
• Gustafson, LW, Hammer, A, Bennetsen, MH, Kristensen, CB, Majeed, H, Petersen, LK, et al. Cervical intraepithelial neoplasia in women with transformation zone type 3: cervical biopsy versus large loop excision. BJOG 129(13): 2132– 2140. doi.org/10.1111/1471-0528.17200
  
  
• Gustafson LW, Tranberg M, Christensen PN, Brøndum R, Wentzensen N, Clarke MA. Clinical utility of p16/Ki67 dual-stain cytology for detection of cervical intraepithelial neoplasia grade two or worse in women with a transformation zone type 3: A cross-sectional study. BJOG: Int J Obstet Gy. 2022; 00: 1– 8. https://doi.org/10.1111/1471-0528.17248
  
  
• Hansen, J, Kirkegaard, P, Folmann, B, Bungum, HF, Hammer, A. “I feel reassured, but there is no guarantee.” How do women with a future childbearing desire respond to active surveillance of cervical intraepithelial neoplasia grade 2? A qualitative study. Acta Obstet Gynecol Scand 101: 616– 623. doi.org/10.1111/aogs.14354
  
  
• Helgestad ADL, Larsen MB, Njor S, et al. Three birds with one stone: a protocol for a randomised intervention study to increase participation in cervical and colorectal cancer screening among women attending breast cancer screening. BMJ Open 12: e062824. doi.org/10.1136/bmjopen-2022-062824  
   
• Ivarsson L, de la Campa MAS, Elfving K, Yin H, Gullsby K, Stark L, Andersen B, Hoffmann S, Gylfe Å, Unemo M, Herrmann B. Changes in testing and incidence of Chlamydia trachomatis and Neisseria gonorrhoeae – the possible impact of the COVID-19 pandemic in the three Scandinavian countries. Infectious Diseases 54: 623-631. DOI: 10.1080/23744235.2022.2071461 
  
  
• Jørgensen, SF, Andersen, B, Petersen, LK, Rebolj, M, Njor, SH. Adherence to follow-up after the exit cervical cancer screening test at age 60–64: A nationwide register-based study. Cancer Med. 11:224-237. doi.org/10.1002/cam4.4420
  
  
• Kleif, J, Jørgensen, LN, Hendel, JW et al. Early detection of colorectal neoplasia: application of a blood-based serological protein test on subjects undergoing population-based screening. Br J Cancer 126:1387-1393. doi.org/10.1038/s41416-022-01712-x
  
  
• Larsen, MB, Hedelund, M, Flander, L, Andersen, B. The impact of pre-notifications and reminders on participation in colorectal cancer screening – A randomised controlled trial. Preventive Medicine 164, 107229. doi.org/10.1016/j.ypmed.2022.107229 
  
  
• Larsen, MB, Stokholm, R, Kirkegaard, P, Laursen, HS, Gabel, P, Andersen, B. Making decisions on your own: Self-administered decision aids about colorectal cancer screening – A systematic review and meta-analyses. Patient Education and Counseling 534-546. doi.org/10.1016/j.pec.2021.07.035
  
  
• Larsen, MB, Søborg, B, Njor, SH, Jensen, TM, Ingeholm, P, Andersen, B. The relative effectiveness of fecal immunochemical test-based colorectal cancer screening to detect adenomas and cancer in different demographic and socioeconomic groups. A nationwide cohort study. European Journal of Cancer Prevention 31: 489-496. doi.org/10.1097/CEJ.0000000000000735.
  
  
• Larsen, PT, Rasmussen, M, Njor, SH. Data from the Nielsen et al. study does not support their suggestion. Colorectal Disease 24(1): 133-134.doi: 10.1111/codi.15967.
  
  
• Larsen, PT, Jørgensen, SF, Njor, SH. Colorectal cancer screening participation among citizens not recommended to be screened: a cohort study. BMC Gastroenterololy 22 (256). doi.org/10.1186/s12876-022-02331-9. 
  
  
• Njor SH, Larsen MB, Søborg B, Andersen B. Colorectal cancer mortality after randomized implementation of FIT-based screening - a nationwide cohort study. Journal of Medical Screening. E-pub ahead of print. doi:10.1177/09691413221102212
   
• Njor, SH, Rasmussen, M, Friis-Hansen, L, Andersen, B. Varying fecal
  immunochemical test screening cut-offs by age and gender: a way to increase detection rates and reduce number of colonoscopies. Gastrointestinal Endoscopy 95(3): 540-549. doi.org/10.1016/j.gie.2021.09.038 
  
  
• Olesen TB, Jensen H, Møller H, Jensen JW, Waldstrøm M, Andersen B. Participation in the nation-wide cervical cancer screening programme in Denmark during the COVID-19 pandemic: An observational study. eLife 12:e81522. doi.org/10.7554/eLife.81522.
  
  
• Rebolj M, Sargent A, Njor SH, Cuschieri K. Widening the offer of human papillomavirus self-sampling to all women eligible for cervical screening: Make haste slowly. Int J Cancer. 2022; 1- 12. doi:10.1002/ijc.34358

• Badre-Esfahani, S, Petersen, LK, Tatari, CR, Blaakær, J, Andersen, B, Seibæk, L. Perceptions of cervical cancer prevention among a group of ethnic minority women in Denmark - A qualitative study. PLoS ONE 16(6): e0250816. doi.org/10.1371/journal.pone.0250816
  
  
• Bulliard, J-L, Beau, A-B, Njor, S, Wu, WY, Procopio, P, Nickson, C, Lynge, E. Breast cancer screening and overdiagnosis. Int. J. Cancer 149: 846–853. doi.org/10.1002/ijc.33602
  
  
• Fogh, K, Strange, JE, Scharff, BFSS, Eriksen, ARR, Hasselbalch, RB, Bundgaard, H, Nielsen, SD, Jørgensen, CS, Erikstrup, C, Norsk, J, Nielsen, PB, Kristensen, JH, Østergaard, L, Ellermann-Eriksen, S, Andersen, B et al. Testing Denmark: A Danish nationwide surveillance study of COVID-19. Microbiology Spectrum 9(3): e01330-21. doi.org/10.1101/2021.08.10.2126177
  
  
• Gustafson, LW, Booth, BB, Kahlert, J, Ørtoft, G, Mejlgaard, E, Clarke, MA, Wentzensen, N, Rositch, AF, Hammer, A. Trends in hysterectomy‐corrected uterine cancer mortality rates during 2002 to 2015: mortality of nonendometrioid cancer on the rise? Int. J. Cancer 148: 584–592. doi.org/10.1002/ijc.33219
  
  
• Gustafson, LW, Petersen, LK, Bor, P, Andersen, B, Hammer, A. Cervical cancer prevention among older women – challenges in screening, diagnostic workup, and treatment. Acta Obstetricia et Gynecologica Scandinavica 100(8):1364-1368. doi.org/10.1111/aogs.14162
  
  
• Jørgensen, SF, Andersen, B, Lernevall, A, Rebolj, M, Njor, SH. Variations in pathways and resource use in follow-up after abnormal mammography screening: a nationwide register-based study. Breast Cancer Res Treat 189: 551-560. doi.org/10.1007/s10549-021-06312-6
  
  
• Jørgensen, SF, Andersen, B, Rebolj, M, Njor, SH. Gaps between recommendations and their implementation: A register-based study of follow-up after abnormalities in cervical cancer screening. Preventive Medicine 146: 106468. doi.org/10.1016/j.ypmed.2021.106468.
  
  
• Kirkegaard, P, Edwards, A, Andersen, B. Balancing risks: Qualitative study of attitudes, motivations and intentions about attending for mammography during the COVID-19 pandemic. Scandinavian Journal of Public Health 49: 700-706. doi:10.1177/14034948211002648
  
  
• Larsen, MB, Bachmann, HH, Søborg, B, Laurberg, T, Emmertsen, KJ, Laurberg, S, Andersen, B. Prevalence of self-reported abdominal symptoms among 50–74-years-old men and women eligible for colorectal cancer screening –a cross-sectional study. BMC Cancer 21: 910. doi.org/10.1186/s12885-021-08657-z
  
  
• Njor, SH, Andersen, B, Friis‐Hansen, L, de Haas, N, Linnemann, D, Nørgaard, H, Roikjær, O, Søndergaard, B, Rasmussen, M. The optimal cut‐off value in fit‐based colorectal cancer screening: An observational study. Cancer Medicine 10:1872-1879. doi.org/10.1002/cam4.3761
  
  
• St-Martin, G, Viborg, PH, Andersen, ABT, Andersen, B, Christensen, J, Ejersbo, D, Heje, HN, Jochumsen, KM, Johansen, T, Larsen, LG, Lynge, E, Serizawa, RR, Waldstrøm, M. Histological outcomes in HPV-screened elderly women in Denmark. PLoS ONE 16(2): e0246902. doi.org/10.1371/journal.pone.0246902
   
• St-Martin, G, Thamsborg, LH, Andersen, B, Christensen, J, Ejersbo, D, Jochumsen, K, Johansen, T, Larsen, LG, Waldstrøm, M, Lynge, E. Management of low-grade cervical cytology in young women. Cohort study from Denmark. Acta Oncologica 60(4):444-451. doi.org/10.1080/0284186X.2020.1831061
  
  
• Tatari, CR, Andersen, B, Brogaard, T, Badre-Esfahani, S, Jaafar, N, Kirkegaard, P. The SWIM study: Ethnic minority women's ideas and preferences for a tailored intervention to promote national cancer screening programme  - A qualitative interview study. Health Expectations. E-pub ahead of print. doi.org/10.1111/hex.13309 
  
  
• Wilhelmsen, M, Njor, SH, Roikjær, O, Rasmussen, M, Gögenur, I. Impact of screening on short-term mortality and morbidity following treatment for colorectal cancer. Scandinavian Journal of Surgery 110(4): 465-471. doi: 10.1177/14574969211019824.

• Andersen B, Njor SH, Jensen AMS, Johansen, T, Jeppesen U, Svanholm, H. HrHPV testing vs liquid-based cytology in cervical cancer screening among women aged 50 and older: a prospective study.

  International Journal of Gynecological Cancer 30: 1678-1683. doi.org/10.1136/ijgc-2020-001457
  
  
• Badre-Esfahani S, Larsen MB, Seibæk L, Petersen LK, Blaakær J, Andersen B. Low attendance by non-native women to human papillomavirus vaccination and cervical cancer screening – A Danish nationwide register-based cohort study. Preventive Medicine Reports 19, Article 101106. doi.org/10.1016/j.pmedr.2020.101106
  
  
• Fredsøe, J, Koetsenruyter, J, Vedsted, P, Kirkegaard, P, Væth, M, Edwards, A, Ørntoft, TF, Sørensen, KD, Bro, F. The effect of assessing genetic risk of prostate cancer on the use of PSA tests in primary care: A cluster randomized controlled trial. PLoS Med 17(2):
  e1003033. doi.org/10.1371/journal.pmed.1003033
  
  
• Fredsøe, J, Kirkegaard, P, Edwards, A, Vedsted, P, Sørensen, KD, Bro, F. A genetic risk assessment for prostate cancer influences patients’ risk perception and use of repeat PSA testing: a cross-sectional study in Danish general practice. BJGP Open 4(2): bjgpopen20X101039. doi.org/10.3399/bjgpopen20X101039
  
  
• Gabel P, Edwards A, Kirkegaard P, Larsen MB, Andersen B. The LEAD trial - The effectiveness of a decision aid on decision making among citizens with lower educational attainment who have not participated in FIT-based colorectal cancer screening in Denmark: A randomised controlled trial. Patient Education and Counselling 103(2): 359-368. doi.org/10.1016/j.pec.2019.08.029
  
  
• Gabel P, Larsen MB, Edwards A, Kirkegaard P, Andersen B. Effectiveness of a decision aid for colorectal cancer screening on components of informed choice according to educational attainment: A randomised controlled trial. PLOS ONE 15(11): e0241703. doi.org/10.1371/journal.pone.0241703
  
  
• Gustafson, LW, Gabel, P, Hammer, A, Lauridsen, HH, Petersen, LK, Andersen, B, Bor, P, Larsen, MB. Validity and reliability of State-Trait Anxiety Inventory in Danish women aged 45 years and older with abnormal cervical screening results. BMC Med Res Methodol 20: 89. doi.org/10.1186/s12874-020-00982-4
  
  
• Hammer, A, Gustafson, LW, Christensen, PN, Brøndum, R, Andersen, B, Andersen, RH, Tranberg, M. Implementation of p16/Ki67 dual stain cytology in a Danish routine screening laboratory: Importance of adequate training and experience. Cancer Med. 9(21): 8235-8242. doi.org/10.1002/cam4.3399
  
  
• Horshauge, PM, Gabel, P, Larsen, MB, Kirkegaard, P, Edwards, A, Andersen, B. The association between health literacy and colorectal cancer screening uptake in a publicly funded screening program in Denmark: Cross-sectional study. Preventive Medicine Reports 19 101132. doi.org/10.1016/j.pmedr.2020.101132
  
  
• Kirkegaard P, Gustafson LW, Petersen LK, Andersen B. ‘I Want the Whole Package’. Elderly Patients’ Preferences for Follow-Up After Abnormal Cervical Test Results: A Qualitative Study. Patient Prefer Adherence 14:1185-1193. doi.org/10.2147/PPA.S259095
  
  
• Larsen, MB, Vejborg, I, Njor, SH. Participation in breast cancer screening among breast cancer survivors –A nationwide register-based cohort study. The Breast 54: 31-36. doi.org/10.1016/j.breast.2020.08.012
  
  
• Larsen, MB, Njor, S, Jensen, TM, Ingeholm, P, Andersen, B. Answer to: Letter to the editor regarding ‘Potential for prevention: a cohort study of colonoscopies and removal of adenomas in a FIT-based colorectal cancer screening programme’. Scandinavian Journal of Gastroenterology 55:6, 761. doi:10.1080/00365521.2020.1774801
  
  
• Larsen, PT, Jørgensen, SF, Tranberg, M, Njor, S. Screening participation after a false positive result in organized cervical cancer screening: a nationwide register-based cohort study. Scientific Reports 10: 15427. doi.org/10.1038/s41598-020-72279-x
  
  
• Lynge, E, Thamsborg, L, Larsen, LG, Christensen, J, Johansen, T, Hariri, J, Christiansen, S, Rygaard, C, Andersen, B. Prevalence of high-risk human papillomavirus after HPV-vaccination in Denmark. Int J Cancer 147: 3446– 3452. doi:10.1002/ijc.33157
  
  
• Lynge, E, Beau, AB, von Euler-Chelpin, M, Napolitano, G, Njor, S, Olsen, AH, Schwartz W, Vejborg, I. Breast cancer mortality and overdiagnosis after implementation of population-based screening in Denmark. Breast Cancer Res Treat 184: 891-899. doi.org/10.1007/s10549-020-05896-9
  
  
• Njor, SH, Vejborg, I, Larsen, MB. Breast cancer survivors' risk of interval cancers and false positive results in organized mammography screening. Cancer Med. 9: 6042– 6050. doi.org/10.1002/cam4.3182 

• Njor, S, Lynge, E. Loss of QALY in mammography screening reported by Zahl et al. Int. J. Cancer: 146, 1176. doi.org/10.1002/ijc.32754
  
  
• Tatari, CR, Andersen, B, Brogaard, T, Badre-Esfahani, SK, Jaafar, N, Kirkegaard, P. Perceptions about cancer and barriers towards cancer screening among ethnic minority women in a deprived area in Denmark – a qualitative study. BMC Public Health 20: 921. doi.org/10.1186/s12889-020-09037-1
  
  
• Tranberg, M, Petersen, LK, Elfström, KM, Hammer, A, Blaakær, J, Bennetsen, MH, Jensen, JS, Andersen, B. Expanding the upper age limit for cervical cancer screening: a protocol for a nationwide non-randomised intervention study. BMJ Open 10: e039636. doi: 10.1136/bmjopen-2020-039636
  
  
• Tranberg, M, Jensen, JS, Bech, BH, Andersen, B. Urine collection in cervical cancer screening – analytical comparison of two HPV DNA assays. BMC Infectious Disease 20: 926. https://doi.org/10.1186/s12879-020-05663-7
  
  
• Zøylner IA, Kirkegaard P, Christiansen PM, Lomborg K. Patient involvement in the development of the Danish surgical breast cancer patient pathway – An action research project. Action Research. October 2020. doi:10.1177/1476750320960819

• Andersen B, Christensen BS, Christensen J, Ejersbo D, Heje HN, Jochumsen KM, et al. HPV-prevalence in elderly women in Denmark. Gynecol Oncol 154 (1): 118-123. DOI: 10.1016/j.ygyno.2019.04.680.
  
  
• Badre-Esfahani S, Larsen MB, Seibæk L, Petersen LK, Blaakær J, Støvring H, Andersen B. Non-adherence to childhood HPV vaccination is associated with non-participation in cervical cancer screening – a nationwide Danish register-based cohort study. Clinical Epidemiology 11: 969-980. DOI:10.2147/CLEP.S203023.
  
  
• Baumann A, Andersen B, Ostergaard L, Larsen MB. Sense & sensibility: Decision-making and sources of information in mothers who decline HPV vaccination of their adolescent daughters. Vaccine X 2: 100020. DOI: 10.1016/j.jvacx.2019.100020.
  
  
• Gabel P, Larsen MB, Edwards A, Kirkegaard P, Andersen B. Knowledge, attitudes, and worries among different health literacy groups before receiving first invitation to colorectal cancer screening: Cross-sectional study. Prev Med Rep 14: 100876. DOI: 10.1016/j.pmedr.2019.100876.
  
  
• Jørgensen SF, Njor SH. Letter to Editor: Higher cervical cancer mortality among older women in Denmark could be due to insufficient screening coverage. Acta Obstetricia et Gynecologica Scandinavica 98 (11): 1489-1490. DOI: 10.1111/aogs.13685.
  
  
• Kirkegaard P, Edwards A, Andersen B. A stitch in time saves nine: Perceptions about colorectal cancer screening after a non-cancer colonoscopy result. Qualitative study. Patient Education and Counselling 102 (7): 1373-1379. DOI: 10.1016/j.pec.2019.02.025.
  
  
• Kristiansen BK, Andersen B, Bro F, Svanholm H, Vedsted P. Direct notification of cervical cytology results to women improves follow-up in cervical cancer screening - A cluster-randomised trial. Preventive Medicine Reports 13: 118-125. DOI: 10.1016/j.pmedr.2018.11.015.
  
  
• Laforest F, Kirkegaard P, Mann B, Edwards A. Genetic cancer risk assessment in general practice: systematic review of tools available, clinician attitudes and outcomes for patients. British Journal of General Practice 69(679):e97-e105. DOI: 10.3399/bjgp18X700265.
  
  
• Larsen MB, Njor SH, Jensen TM, Ingeholm P, Andersen B. Potential for prevention: a cohort study of colonoscopies and removal of adenomas in a FIT-based colorectal cancer screening programme. Scandinavian Journal of Gastroenterology 54(8): 1008-1014. DOI: 10.1080/00365521.2019.1647282.
  
  
• Lund M, Erichsen R, Njor SH, Laurberg S, Valori R, Andersen B. The performance indicator of colonic intubation (PICI) in a FIT-based colorectal cancer screening program. Scandinavian Journal of Gastroenterology 54 (9): 1176-1181. DOI: 10.1080/00365521.2019.1648548.
  
  
• Lund M, Trads M, Njor SH, Erichsen R, Andersen B. Quality indicators for screening colonoscopy and colonoscopist performance and the subsequent risk of interval colorectal cancer: a systematic review. JBI Database of Systematic Reviews and Implementation Reports 17 (11): 2265–2300. DOI: 10.11124/JBISRIR-2017-003927.
  
  
• Lund M, Erichsen R, Valori R, Moller Jensen T, Helle Njor S, Laurberg S, et al. Data quality and colonoscopy performance indicators in the prevalent round of a FIT-based colorectal cancer screening program. Scandinavian Journal of Gastroenterology 54 (4): 471-477. DOI: 10.1080/00365521.2019.1597158.
  
  
• Njor SH, Rasmussen M, Friis-Hansen L, Andersen B. Answer to: "Is the National Danish Colorectal Cancer Screening Programme a success?". Cancer Epidemiol 58: 200. DOI: 10.1016/j.canep.2018.12.009.
  
  
• Njor SH, Lynge E. Loss of QALY in mammography screening reported by Zahl et al. International Journal of Cancer 146 (4): 1176. DOI: 10.1002/ijc.32754.
  
  
• Zøylner IA, Lomborg K, Christiansen PM, Kirkegaard P. Surgical breast cancer patient pathway: Experiences of patients and relatives and their unmet needs. Health Expectations 22 (2): 262-272. DOI: 10.1111/hex.12869.

• Davies B, Turner KME, Benfield T, Frølund M, Andersen B, Westh H, Danish Chlamydia Study group, Ward H. Pelvic inflammatory disease risk following negative results from chlamydia nucleic acid amplification tests (NAATs) versus non-NAATs in Denmark: A retrospective cohort. PLoS Medicine 2, 15 (1):e1002483. DOI: 10.1371/journal.pmed.1002483.
  
  
• Gabel P, Kirkegaard P, Larsen MB, Edwards A, Andersen B. Developing a Self-Administered Decision Aid for Fecal Immunochemical Test-Based Colorectal Cancer Screening Tailored to Citizens With Lower Educational Attainment: Qualitative Study. JMIR Formative Research 2:e9. DOI: 10.2196/formative.9696
  
  
• Gabel P, Larsen MB, Kirkegaard P, Edwards A, Andersen B. The LEAD trial - the effectiveness of a decision aid on decision making among citizens with lower educational attainment who have not participated in FIT-based colorectal cancer screening in Denmark: study protocol for a randomized controlled trial. Trials 19: 543. DOI:10.1186/s13063-018-2921-z.
  
  
• Hanley JA, Njor SH. Disaggregating the mortality reductions due to cancer screening: model-based estimates from population-based data. Eur J Epidemiol 33 (5): 465-472. DOI: 10.1007/s10654-017-0339-7.
  
  
• Juul JS, Andersen B, Laurberg S, Carlsen AH, Olesen F, Vedsted P. Differences in diagnostic activity in general practice and findings for individuals invited to the Danish screening programme for colorectal cancer: a population-based cohort study. Scand J Prim Health Care 36 (3): 281-290. DOI: 10.1080/02813432.2018.1487378.
  
  
• Juul JS, Hornung N, Andersen B, Laurberg S, Olesen F, Vedsted P. The value of using the faecal immunochemical test in general practice on patients presenting with non-alarm symptoms of colorectal cancer. BJC British Journal of Cancer 119: 471–479. DOI: 10.1038/s41416-018-0178-7.
  
  
• Kirkegaard P, Edwards A, Larsen MB, Andersen B.
  Waiting for diagnostic colonoscopy: a qualitative exploration of screening participants’ experiences in a FIT-based colorectal cancer screening program. Patient Prefer Adherence 12: 845-852. DOI: 10.2147/PPA.S154959.
  
  
• Kirkegaard P, Edwards A, Nielsen TLO, Ørntoft TF, Sørensen KD, Borre M and Bro F. Perceptions about screening for prostate cancer using genetic lifetime risk assessment: a qualitative study. BMC Family Practice 19:32. DOI: 10.1186/s12875-018-0717-6
  
  
• Larsen MB, Njor S, Ingeholm P, Andersen B. Effectiveness of Colorectal Cancer Screening in Detecting Earlier-stage Disease - a Nationwide Cohort Study in Denmark. Gastroenterology 155:99-106. DOI:0.1053/j.gastro.2018.03.062
  
  
• Larsen SH, Virgilsen LF, Kristiansen BK, Andersen B, Vedsted P. Strong association between cervical and breast cancer screening behaviour among Danish women; A register-based cohort study. Prev Med Rep 12: 349-354. DOI: 10.1016/j.pmedr.2018.10.017.
  
  
• Lynge E, Andersen B, Christensen J, Ejersbo D, Jochumsen K, Johansen T, Kristensen JK, Larsen LG, Mehnert F, Mikkelsen E, Nielsen K, Rygaard C, Serizawa R, Waldstrøm M. Cervical screening in Denmark – a success followed by stagnation. Acta Oncol. 57 (3): 354-361. DOI: 10.1080/0284186X.2017.1355110.
  
  
• Mertz-Petersen M, Piper TB, Kleif J, Ferm L, Christensen IJ, Nielsen HJ; Danish Collaborative Group on Early Detection of Colorectal Neoplasia. Triage for selection to colonoscopy? Eur J Surg Oncol. 44(10):1539-1541. doi: 10.1016/j.ejso.2018.06.013.
  
  
• Mikkelsen EM, Thomsen MK, Tybjerg J, Friis-Hansen L, Andersen B, Jorgensen JCR, et al. Colonoscopy-related complications in a nationwide immunochemical faecal occult blood test-based colorectal cancer screening program. Clin Epidemiol 10: 1649-1655. DOI: 10.2147/CLEP.S181204.
  
  
• Njor SH, Friis-Hansen L, Andersen B, Søndergaard B, Linnemann D, Jørgensen JCR, Roikjær Ole, Rasmussen M. Three years of colorectal cancer screening in Denmark. Cancer Epidemiol 57: 39-44. DOI: 10.1016/j.canep.2018.09.003
  
  
• Njor S, Paci E, Rebolj M. As you like it: How the same data can support manifold views of overdiagnosis in breast cancer screening. Int J Cancer 143 (6): 1287-1294.
  DOI: 10.1002/ijc.31420.
  
  
• Thamsborg LH, Andersen B, Larsen LG, Christensen J, Johansen T, Hariri J, Christiansen S, Rygaard C, Lynge E. Danish method study on cervical screening in women offered HPV vaccination as girls (Trial23): a study protocol. BMJ Open 8 (5): e020294-2017-020294. DOI:10.1136/bmjopen-2017-020294
  
  
• Thomsen MK, Rasmussen M, Njor SH, Mikkelsen EM. Demographic and comorbidity predictors of adherence to diagnostic colonoscopy in the Danish Colorectal Cancer Screening Program: a nationwide cross-sectional study. Clin Epidemiol 10: 1733-1742. DOI: 10.2147/CLEP.S176923.
  
  
• Tranberg M, Bech BH, Blaakær J, Jensen JS, Svanholm H, Andersen B. HPV self-sampling in cervical cancer screening: the effect of different invitation strategies in various socioeconomic groups – a randomized controlled trial. Clinical Epidemiology 10: 1027–1036. DOI: 10.2147/CLEP.S164826.
  
  
• Tranberg M, Jensen JS, Bech BH, Blaakær J, Svanholm H, Andersen B. Good concordance of HPV detection between cervico-vaginal self-samples and general practitioner-collected samples using the Cobas 4800 HPV DNA test. BMC Infectious Diseases 18:348. DOI: 10.1186/s12879-018-3254-y
  
  
• Tranberg M, Bech BH, Blaakær J, Jensen JS, Svanholm H, Andersen B. Preventing cervical cancer using HPV self-sampling: direct mailing of test-kits increases screening participation more than timely opt-in procedures - a randomized controlled trial. BMC Cancer 18(1): 273-018-4165-4. DOI: 10.1186/s12885-018-4165-4
  
  
• Tranberg M, Vedsted P, Bech BH, Christensen MB, Birkeland S, Moth G. Factors associated with low patient satisfaction in out-of-hours primary care in Denmark - a population-based cross-sectional study. BMC Family Practice 19(1): 15. 
  DOI: 10.1186/s12875-017-0681-6.
  
  
• Tranberg M, Andersen B. HPV self-sampling for cervical cancer screening in Denmark [in Danish]. The Journal of the Danish Medical Association 180:V07180475.
  
  
• Virgilsen LF, Pedersen AF, Andersen B, Vedsted P. Non-participation in breast cancer screening among previous cancer patients. Cancer Res and Clin Oncol 144(10):1959-1966. DOI: 10.1007/s00432-018-2734-1.

• Gabel P, Larsen MB, Nielsen PB, Svendstrup DB, Andersen B. Satisfaction, discomfort, obligations, and concerns in population-based breast cancer screening: cross-sectional study in a Danish population. BMC Health Services Research 17(1): 489. DOI: 10.1186/s12913-017-2438-2
  
  
• Kirkegaard P, Larsen MB, Andersen B. Helpline Calling Patterns in a Colorectal Cancer Screening Program: A Cross-sectional Study. Journal of Healthcare Communications 2:2. DOI: 10.4172/2472-1654.100052 

• Kristiansen BK, Andersen B, Bro F, Svanholm H and Vedsted P. Impact of GP reminders on follow-up of abnormal cervical cytology: a before–after study in Danish general practice. Br J Gen Pract 67 (661): e580-e587. DOI: 10.3399/bjgp17X691913
  
  
• Larsen MB, Gabel P, Andersen B. Effectiveness of self-administered decision aids for people invited to participate in colorectal cancer screening: a systematic review protocol. JBI Database of Systematic Reviews and Implementation Reports 15(6): 1552–1560. DOI: 10.11124/JBISRIR-2016-002966
  
  
• Larsen MB, Mikkelsen EM, Jeppesen U, Rasmussen M, Friis-Hansen L, Ovesen A, Rahr HB, Andersen B. Sociodemographic characteristics of nonparticipants in the Danish colorectal cancer screening program: a nationwide cross-sectional study. Clinical Epidemiology 9:345–354. DOI: 10.2147/CLEP.S139168
  
  
• Larsen MB, Mikkelsen EM, Jeppesen U, Svanholm H, Andersen B. The influence of total hysterectomy in a cervical cancer screening population: a register-based cross-sectional study. BMC Health Services Research 17: 423. DOI: 10.1186/s12913-017-2371-4.
  
  
• Lund M, Trads M, Erichsen R, Andersen B: Quality indicators for screening colonoscopies and the risk of interval cancer assessing the performance of colonoscopists: a Systematic review protocol. JBISRIR 15(8): 1991-1997. 
  
  
• Lynge E , Bak M, Von Euler-Chelpin M, Kroman N,
  Lernevall A, Mogensen NB, Schwartz W, Wronecki AJ and Vejborg I. Outcome of breast cancer screening in Denmark. BMC Cancer 17: 897. DOI: 10.1186/s12885-017-3929-6DOI: 10.11124/JBISRIR-2016-003241.
  
  
• Nielsen HJ, Andersen B, Rasmussen M, MiCallef J, Bygott T, Christensen IJ. Serological biomarkers in triage of FIT positive subjects? Scandinavian Journal of Gastroenterology 52(6-7): 742-744. DOI: 10.1080/00365521.2017.1299212
  
  
• Thomsen MK, Njor SH, Rasmussen M, Linnemann D, Andersen B, Baatrup G, Friis-Hansen LJ, Jørgensen JCR, Mikkelsen EM. Validity of data in the Danish Colorectal Cancer Screening Database. Clinical Epidemiology 9: 105-111. DOI: 10.2147/CLEP.S124454

• Andersen B. Kræftscreening for de ressourcestærke – og de svage [in Danish]. The Journal of the Danish Medical Association 23.
  
  
• Andersen B. Screening for livmoderhalskræft hos danske kvinder over 64 år [in Danish]. The Journal of the Danish Medical Association 178(6):V67475.
  
  
• Jensen LF, Pedersen AF, Bech BH, Andersen B, Vedsted P. Psychiatric morbidity and non-participation in breast cancer screening. Breast 25:38-44. DOI: 10.1016/j.breast.2015.10.002
  
  
• Jensen LF, Pedersen AF, Andersen B, Vedsted P. Social support and non-participation in breast cancer screening: a Danish cohort study. Journal of Public Health 38(2):335-42. DOI:10.10093/pubmed/fdv051.
  
  
• Juul JS, Bro F, Hornung N, Andersen BS, Laurberg S, Olesen F, Vedsted P. Implementation of immunochemical faecal occult blood test in general practice: a study protocol using a cluster-randomised stepped-wedge design. BMC Cancer 16:445. DOI: 10.1186/s12885-016-2477-9
  
  
• Larsen MB, Svanholm H, Andersen B. An adverse event in a well-established cervical cancer screening program: an observational study of 19,000 females unsubscribed to the program. Journal of Healthcare Leadership 8:61-69. DOI: 10.2147/JHL.S114462
  
  
• Low N, Redmond S, Uusküla A, van Bergen J, Ward H, Andersen B, Götz H. Screening for genital chlamydia infection. Cochrane Database of Systematic Reviews 9:CD010866. DOI: 10.1002/14651858.CD010866.pub2
  
  
• Lund O, Andersen B, Christensen MK. Old habits die hard: a case study on how new ways of teaching colonoscopy affect the habitus of experienced clinicians. International Journal of Medical Education 7:297-308. DOI: 10.5116/ijme.57d5.5693
  
  
• Rasmussen L, Wilhelmsen M, Christensen IJ, Andersen J, Jørgensen LN, Rasmussen M, Hendel JW, Madsen MR, Vilandt J, Hillig T, Klærke M, Münster AM, Andersen LM, Andersen B, Hornung N, Erlandsen EJ, Khalid A, Nielsen HJ. Protocol Outlines for Parts 1 and 2 of the Prospective Endoscopy III Study for the Early Detection of Colorectal Cancer: Validation of a Concept Based on Blood Biomarkers. JMIR Research Protocols 5(3):e182. DOI: 10.2196/resprot.6346
  
  
• Tranberg M, Hammer Bech B, Blaakær J, Jensen JS,Svanholm H, Andersen B. Study protocol of the CHOiCE trial: a three-armed, randomized, controlled trial of home-based HPV self-sampling for non-participants in an organized cervical cancer screening program. BMC Cancer 2016;6(1):114. DOI: 10.1186/s12885-016-2859-z
  
  
• Van den Broek I, Sfetcu O, Andersen B, Herrmann B, Ward H, Gotz H, Uusküla A, Woodhall S Redmond S, Amato-Gauci A, Low N. Changes in chlamydia control activities in Europe between 2007 and 2012: A cross-national survey. European Journal of Public Health 26(3):382-8. DOI:10.1093/eurpub/ckv196. Læs mere

• Jensen LF, Pedersen AF, Andersen B, Vedsted P. Self-assessed health, perceived stress and non-participation in breast cancer screening: A Danish cohort study. Preventive Medicine 81:392-398. DOI: 10.1016/j.ypmed.2015.10.004.
  
  
• Jensen LF, Pedersen AF, Vestergaard M, Andersen B, Vedsted P. Non-participation in breast cancer screening for persons with chronic diseases and multimorbidity: a population-based cohort study. BMC Cancer 15:798. DOI: 10.1186/s12885-015-1829-1. 
  
  
• Jørgensen MJ, Maindal HT, Christensen KS, Olesen F, Andersen B. Chlamydia trachomatis infection in young adults – association with concurrent partnerships and short gap length between partners. Infectious Diseases 47(12):838-45. DOI: 10.3109/23744235.2015.1071916.
  
  
• Jørgensen MJ, Maindal HT, Christensen KS, Olesen F, Andersen B. Sexual behaviour among young Danes aged 15-29 years: a cross-sectional study of core indicators. Sexually Transmitted Infections 2015;91(3):171-7. DOI: 10.1136/sextrans-2014-051814.
  
  
• Kirkegaard P, Mortensen GL, Mortensen SL, Larsen MB, Gabel P, Andersen B. Making decisions about colorectal cancer screening. A qualitative study among citizens with lower educational attainment. European Journal of Public Health 26(1):176-81.
  DOI:10.1093/eurpub/ckv207.
  
  
• Redmond SM, Alexander-Kisslig K, Woodhall SC, van den Broek IV , van Bergen J, Ward H, Uusküla A, Herrmann B, Andersen B, Götz HM, Sfetcu O, Low N. Genital Chlamydia Prevalence in Europe and Non-European High Income Countries: Systematic Review and Meta-Analysis. PloS One 10(1):e0115753. DOI: 10.1371/journal.pone.0115753. 
  
  
• Tranberg M, Larsen MB, Mikkelsen EM, Svanholm S, Andersen B. Impact of opportunistic testing in a systematic cervical cancer screening program: a nationwide registry study. BMC Public Health 15:681. DOI: 10.1186/s12889-015-2039-0.
  
  
• Tranberg M, Larsen MB, Mikkelsen EM, Svanholm S, Andersen B. Erratum to: Impact of opportunistic testing in a systematic cervical cancer screening program: a nationwide registry study. BMC Public Health 15:893. DOI: 10.1186/s12889-015-2158-7.
   
• Van den Broek I, Sfetcu O, Andersen B, Herrmann B, Ward H, Gotz H, Uusküla A, Woodhall S Redmond S, Amato-Gauci A, Low N. Changes in chlamydia control activities in Europe between 2007 and 2012: A cross-national survey. Eur J Pub Health 26 (3): 382-8. doi:10.1093/eurpub/ckv196.

• Larsen MB, Langagergaard V, Larsson H, Mikkelsen EM, Andersen B. Screening mammography may be a rapid and effective investigation of mamma cancer in asymptomatic women [in Danish]. The Journal of the Danish Medical Association 176: V03140159.

• Larsen MB, Hansen RP, Sokolowski I, Vedsted P. Agreement between patient-reported and doctor-reported patient intervals and date of first symptom presentation in cancer diagnosis: a population-based questionnaire study. Cancer Epidemiology 38(1):100-5. DOI: 10.1016/j.canep.2013.10.006.

• Low N, Redmond S, Alexander K, Van Bergen J, Ward H, Uusküla A, Andersen B, Götz H, Herrmann B, Van den Broek I, Woodhall S. Chlamydia control in Europe: literature review. Stockholm, ECDC. DOI: 10.2900/16352.

• Van den Broek I, Ward H, Uusküla A, Andersen B, Götz H, Herrmann B, Woodhall S. Chlamydia control in Europe - a survey of Member States. Stockholm, ECDC. DOI: 10.2900/30120.

• Jensen LF, Pedersen AF, Andersen B, Fenger-Grøn M, Vedsted P. Distance to screening site and non-participation in screening for breast cancer: a population-based study. Journal of Public Health (Oxford) 36(2):292-9. DOI: 10.1093/pubmed/fdt068.
  
  
• Jensen LF, Andersen B, Vedsted P, En social gradient i deltagelse i brystkræftscreening [in Danish]. Tidsskrift for Dansk Sundhedsvæsen: 0909-6388.
  
  
• Jørgensen MJ. Risikofaktorer og usikker sex blandt unge i Danmark [in Danish]. Best Practice 7-9.
  
  
• Jørgensen MJ, Andersen B, Olesen F, Maindal HT. Young Danes' experiences with unsafe sex. Danish Medical Journal 60(1): A4566.
  
  
• Langagergaard V, Garne JP, Vejborg I, Schwartz W, Bak M, Lernevall A, Mogensen NB, Larsson H, Andersen B, Mikkelsen EM. Existing data sources for clinical epidemiology: the Danish Quality Database of Mammography. Clinical Epidemiology 5:81-8. DOI: 10.2147/CLEP.S40484.
  
  
• Larsen MB, Hansen RP, Hansen DG, Olesen F, Vedsted P. Secondary care intervals before and after the introduction of urgent referral guidelines for suspected cancer in Denmark: a comparative before-after study. BMC Health Services Research 13:348.
  DOI: 10.1186/1472-6963-13-348.
  
  
• Low N, Martin-Hilber A, Röllin A, Redmond S, Scott P, Trelle S, Cassell J, Spencer B, Andersen B, Hawkes S, Herrmann B, Nardone A, Radcliffe K, Stucki C, Wayal S, Uusküla A. Public Health benefits of partner notification for sexually transmitted infections and HIV. Stockholm, ECDC.
  
  
• Low N, Redmond S, Uusküla A, Van Bergen J, Ward H, Andersen B, Götz H, Screening for genital chlamydia infection (Protocol). Cochrane Database of Systematic Reviews 12:1–15. DOI: 10.1002/14651858.CD010866.

• Andersen B, Olesen F. Test for klamydia. For lidt eller for meget? [in Danish] Månedsskrift for almen praksis 11:911.
  
  
• Andersen B, Østergaard L. Klamydia og infertilitet [in Danish]. The Journal of the Danish Medical Association 174(41):2452-2455. 
  
  
• Andersen B, Olesen F. Screening for Chlamydia trachomatis. Screening may not be the next best step. BMJ 345:e4231.
  
  
• Bro F, Andersen B: Screening for livmoderhalskræft. Nye retningslinjer og deres betydning for almen praksis [in Danish]. Månedsskrift for almen praksis 6:534. 
  
  
• Jensen LF, Mukai TO, Andersen B, Vedsted P. The association between general practitioners’attitudes towards breast cancer screening and women’s screening participation. BMC Cancer 12:254. DOI: 10.1186/1471-2407-12-254.
  
  
• Jensen LF, Pedersen AF, Andersen B, Vedsted P. Identifying specific non-attending groups in breast cancer screening - population-based registry study of participation and socio-demography. BMC Cancer 12:518. DOI: 10.1186/1471-2407-12-518.
  
  
• Jensen LF. Association mellem den praktiserende læges holdning til brystkræftscreening og kvindernes deltagelse i programmet [in Danish]. Månedsskrift for almen praksis.
  
  
• Low N, Cassell J, Spencer B, Bender N, Hilber AM, van Bergen J, Andersen B, Herrmann B, Dubois-Arber F, Hamers FE, van de Laar M, Stephenson J. Chlamydia control activities in Europe: cross-sectional survey. European Journal of Public Health 22(4):556-61. DOI: 10.1093/eurpub/ckr046.
  
  
• Vejborg I, Mikkelsen EM, Schwartz W, Bak M, Lernevall A, Mogensen NB, Garne JP. Dansk Kvalitetsdatabase for Mammografiscreening [in Danish]. The Journal of the Danish Medical Association 174(41):2533. 

• Andersen B, Van Valkengoed I, Sokolowski I, Østergaard L, Møller JK, Olesen F. Impact of intensified testing for urogenital Chlamydia trachomatis infections: a randomised study with 9-year follow-up. Sexual Transmitted Infections 87(2):156-61.
  DOI: 10.1136/sti.2010.042192.
  
  
• Bender N, Herrmann B, Andersen B, Hocking JS, Scherer M, Low N. Chlamydia infection, pelvic inflammatory disease, ectopic pregnancy, and infertility: cross-national study. Sexually Transmitted Infections 87(7):601-8. DOI: 10.1136/sextrans-2011-050205.
  
  
• Bock K, Borisch B, Cawson J, Damtjernhaug B, de Wolf C, Dean P, den Heeten A, Doyle G, Fox R, Frigerio A, Gilbert F, Hecht G, Heindel W, Heywang-Köbrunner SH, Holland R, Jones F, Lernevall A, Madai S, Mairs A, Muller J, Nisbet P, O'Doherty A, Patnick J, Perry N, Regitz-Jedermann L, Rickard M, Rodrigues V, Del Turco MR, Scharpantgen A, Schwartz W, Seradour B, Skaane P, Tabar L, Tornberg S, Ursin G, Van Limbergen E, Vandenbroucke A, Warren LJ, Warwick L, Yaffe M, Zappa M. Effect of population-based screening on breast cancer mortality. Lancet 378(9805):1775-6. DOI: 10.1016/S0140-6736(11)61766-2.
  
  
• Jørgensen MJ, Andersen B, Terkildsen M, Olesen F. Usikker sex blandt unge danskere [in Danish]. Månedsskrift for almen praksis:726-732.
  
  
• Leutscher P, Laursen T, Andersen B, Ostergaard L, Laursen A, Schade C. HIV late presenters in Denmark – need for increased diagnostic awareness among general practitioners. Danish Medical Bulletin 58(4):A4253. 
  
  
• Vejborg I, Mikkelsen E, Garne JP, Bak M, Lernevall A, Mogensen NB, Schwartz W, Lynge E. Mammography screening in Denmark. Danish Medical Bulletin 58(6):C4287.

• Gustafson, L, Tranberg, M, Christiansen, A, Lapirtis, H, Krogh, L, Hjorth, I, Hammer, A, Booth, B. Clinical management of older postmenopausal women referred for colposcopy due to an abnormal screening test. Eurogin, virtual.
  
  
• Gustafson, L. CIN2+ may be underestimated in older women when using punch biopsies as outcome measure. 34th International Papillomavirus Conference, virtual.
  
  
• Gustafson, L. Performance of p16/ki67 dual stain-cytology for detection of cin2+ among older women with a transformationzone type 3. 34th International Papillomavirus Conference, virtual. 
  
  
• Hansen, J, Kirkegaard, P, Bungum, HF, Folmann, B, Hammer, A. 'I feel reassured but there is no guarantee'. How do women of childbearing age respond to active surveillance for moderate cervical dysplasia? A qualitative study. Danske Kræftforskningsdage, Odense, Denmark.
  
  
• Helgestad, ADL, Larsen, MB, Tranberg, M, Petersen, LK, Njor, SH, Andersen B. Research protocol: Can we kill three birds with one stone? A randomised controlled trial to increase participation in cervical and colorectal cancer screening. Danske Kræftforskningsdage, Odense, Denmark.
  
  
• Jørgensen, SF, Andersen, B, Rebolj, M, Njor, SH. Gaps between recommendations and their  implementation: A register-based study of follow-up after abnormalities in cervical cancer screening. Danske Kræftforskningsdage, Odense, Denmark.
  
  
• Jørgensen, SF. Adherence to follow-up after positive HPV-tests among women aged 60-64 - a Danish register-based cohort study, Eurogin, virtual.
  
  
• Jørgensen, SF. Adherence to follow-up after non-negative HPV-tests among women aged 60-64 and the associated resource use: A register-based cohort study, Klinisk Kvalitetskonference, Aalborg, Denmark.
  
  
• Kirkegaard, P, Edwards, A, Andersen, B. Balancing risks: Qualitative study of attitudes, motivations and intentions about
  attending for mammography during the COVID-19 pandemic. Danske Kræftforskningsdage, Odense, Denmark. 
  
  

• Larsen, MB. Effect of screening for colorectal cancer in Denmark. Danske Kræftforskningsdage, Odense, Denmark. 

• Larsen, PT, Jørgensen, SF, Tranberg, M, Njor, SH. Screening participation after a false positive result, Eurogin, virtual.
  
  
• Laurberg, T, Nannsen, A, Hansen LB, Larsen, MB, Andersen B, Sandbæk, A. The effect of the Danish National colorectal screening program on detecting cancer for patients with diabetes. Danske Kræftforskningsdage, Odense, Denmark. 
  
  
• Tranberg, M, Gustafson, L, Christensen, P, Brøndum, R, Andersen, B, Andersen, R, Hammer, A. Introduction of p16/Ki67 dual stain cytology in a Danish routine screening laboratory: lessons learned, Eurogin, virtual.
  
  
• Tranberg M, Jensen, J, Bech, B, Andersen, B. Urine HPV-DNA detection for cervical cancer screening - analytical comparison of two HPV assays, Eurogin, virtual.

Due to the COVID-19 pandemic, the Department had no conference activities in 2020.

• Gustafson, LW. Trends in hysterectomy-corrected uterine cancer mortality rates during 2002-2015: mortality of non-endometrioid cancer on the rise? ESGO, Athens, Greece (poster)
  
  
• Jørgensen SF, Andersen B, Rebolj M, Njor SH. Timely follow-up of abnormalities in cervical cancer screening. International Cancer Screening Conference, Rotterdam, The Netherlands (poster)
  
  
• Jørgensen SF, Andersen B, Rebolj M, Njor SH. Healthcare resources for investigation and treatment of abnormalities in cervical cancer screening. Association of the Nordic Cancer Registries Symposium, Stockholm, Sweden (poster + oral)
  
  
• Kirkegaard P, Edwards A, Andersen B. Perceptions about colorectal cancer screening after a non-cancer colonoscopy result. International Cancer Screening Conference, Rotterdam, the Netherlands (poster)
  
  
• Kirkegaard P, Gustafson LW, Petersen LK, Andersen B. Safety first: Older women's experiences with colposcopy and preferences for follow-up after abnormal cervical cytology. EUROGIN International Multidisciplinary HPV Congress, Monaco (poster)
  
  
• Kirkegaard P, Gustafson LW, Petersen LK, Andersen B. Safety first: Older women's experiences with colposcopy and preferences for follow-up after abnormal cervical cytology. 8th European Federation of Colposcopy Congress, Rome, Italy (poster)
  
  
• Kristiansen BK. Direct notification of cervical cytology results to women improves follow–up. International Cancer Screening Conference, Rotterdam, The Netherlands (poster)
  
  
• Koed Badre-Esfahani, S. Women not HPV-vaccinated as children are less likely to attend cervical cancer screening. EUROGIN conference, Monaco (oral)
  
  
• Koed Badre-Esfahani, S. Ethnic disparity in Denmark - HPV vaccination and cervical cancer screenings attendance. Danish Cancer Research Days (poster).
  
  
• Larsen MB. Differentiated effectiveness of colorectal cancer screening according to socioeconomic status - A nationwide cohort study. International Cancer Screening Conference, Rotterdam, The Netherlands (oral)
  
  
• Larsen TL. Screening participation after a false-positive cervical cytology in organized cervical cancer screening: A nationwide register-based cohort study. Association of the Nordic Cancer Registries Symposium, Stockholm, Sweden (poster+oral)
  
  
• Njor SH. What not to do when estimating overdiagnosis in breast cancer screening. International Cancer Screening Conference, Rotterdam, The Netherlands (oral)
  
  
• Njor SH. Optimizing FIT screening by using different cut-off values for different age groups and sex. International Cancer Screening Conference, Rotterdam, The Netherlands (oral)
  
  
• Njor SH. What not to do when estimating overdiagnosis in breast cancer screening. Association of the Nordic Cancer Registries Symposium, Stockholm, Sweden (oral)
  
  
• Tranberg M. Compliance to follow-up among HPV-positive self-samplers. Eurogin, Monaco (oral, invited speaker)
  
  
• Tranberg M. Offering cervical cancer screening to older women. Eurogin, Monaco (oral, invited speaker)
  
  
• Tranberg M. Ulighed i kræft- hvordan løfter vi sammen: Nye teknologiske muligheder – hjemmeprøve for HPV. DMCG and Danish Cancer Society, Christiansborg Palace, Denmark (oral, invited speaker)
  
  
• Tranberg M. HPV self-sampling is a promising tool to reduce the social inequality in screening participation. International Cancer Screening Conference, Rotterdam, The Netherlands (oral)

• Andersen B. A 5-year follow-up study of the diagnostic efficacy using primary hrHPV testing vs. liquid based cytology in cervical cancer screening of women aged 50+. Eurogin, Lisbon, Portugal (oral)
  
  
• Bauman A. Sense and sensibility: Sources of information in mothers who reject HPV-vaccination of their adolescent daughters. Eurogin, Lisbon, Portugal (oral)
  
  
• Badre-Esfahani S. Adherence to HPV vaccination is associated with participation in cervical cancer screening – a Danish national register-based cohort study. Eurogin, Lisbon, Portugal (poster)
  
  
• Gabel P. Communicating detailed information about colorectal cancer screening to citizens with lower educational attainment using an electronic decision aid: a qualitative study. Society for Medical Decision Making (SMDM), Rotterdam, the Netherlands (poster)
  
  
• Kirkegaard P, Edwards A, Andersen B. Perceptions of subsequent screening after a false alarm for cancer. Society for Medical Decision Making (SMDM), Rotterdam, the Netherlands (poster)
  
  
• Tranberg M. HPV self-sampling is a promising tool to reduce social inequality in screening participation, Eurogin, Lisbon, Portugal (oral)

• Gabel P. A decision aid respecting individual information needs. International Cancer Screening Conference, Bethesda, Maryland, USA (poster)
  
  
• Kristiansen BK. Direct notification of cervical cytology results to women improves follow–up. . International Cancer Screening Conference, Bethesda, Maryland, USA (poster)
  
  
• Kristiansen BK. Gynaecological Cancers – a challenge for the general practitioner and the healthcare system. 20th Nordic Congress of General Practice, Reykjavik, Iceland (oral)
  
  
• Larsen MB. Sociodemographic characteristics of non-participants in colorectal cancer screening. International Cancer Screening Conference, Bethesda, Maryland, USA (poster)
  
  
• Njor SH. Studies with low vs. high estimates of overdiagnosis: what is the difference? International Cancer Screening Conference, Bethesda, Maryland, USA, (poster)
  
  
• Tranberg M. The CHOiCE trial: a randomized, controlled effectiveness trial of HPV self-sampling for non-participants in an organized cervical cancer screening program. International Cancer Screening Conference, Bethesda, Maryland, USA, (oral and poster)
  
  
• Tranberg M. THE CHOiCE TRIAL: A randomized, controlled effectiveness trial of HPV self-sampling for non-participants in an organized cervical cancer screening program. Eurogin, Amsterdam, The Netherlands, (oral)

• Andersen B. Observations from an adverse event: Re-establishing the cervical cancer screening programme in Central Denmark Region. Eurogin, Salzburg, Austria (oral)
  
  
• Kristiansen BK. Reminders to general practitioners improve follow-up after abnormal or inadequate cervical cytology – a nationwide before and after cohort study, WONCA Europe Conference, Copenhagen, Denmark (oral)
  
  
• Tranberg M. Study protocol of the CHOiCE trial: A three-armed, randomized, controlled trial of home-based HPV self-sampling for non-participants in an organized cervical cancer screening program. Eurogin, Salzburg, Austria (poster)